SG Americas Securities’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,884
| Closed | -$633K | – | 2635 |
|
|
2025
Q1 | $633K | Buy |
34,884
+9,601
| +38% | +$174K | ﹤0.01% | 1419 |
|
|
2024
Q4 | $639K | Buy |
25,283
+4,967
| +24% | +$126K | ﹤0.01% | 978 |
|
|
2024
Q3 | $691K | Buy |
20,316
+11,272
| +125% | +$383K | ﹤0.01% | 1226 |
|
|
2024
Q2 | $335K | Sell |
9,044
-11,232
| -55% | -$416K | ﹤0.01% | 1723 |
|
|
2024
Q1 | $851K | Sell |
20,276
-25,807
| -56% | -$1.08M | ﹤0.01% | 1084 |
|
|
2023
Q4 | $1.83M | Sell |
46,083
-31,928
| -41% | -$1.27M | 0.02% | 641 |
|
|
2023
Q3 | $2.15M | Buy |
78,011
+73,079
| +1,482% | +$2.01M | 0.02% | 618 |
|
|
2023
Q2 | $167K | Sell |
4,932
-5,457
| -53% | -$185K | ﹤0.01% | 1629 |
|
|
2023
Q1 | $374K | Buy |
10,389
+3,587
| +53% | +$129K | ﹤0.01% | 1767 |
|
|
2022
Q4 | $303K | Sell |
6,802
-6,266
| -48% | -$279K | ﹤0.01% | 1715 |
|
|
2022
Q3 | $367K | Sell |
13,068
-42,687
| -77% | -$1.2M | ﹤0.01% | 1610 |
|
|
2022
Q2 | $1.5M | Buy |
55,755
+41,795
| +299% | +$1.13M | 0.02% | 824 |
|
|
2022
Q1 | $475K | Buy |
13,960
+3,873
| +38% | +$132K | ﹤0.01% | 1711 |
|
|
2021
Q4 | $390K | Sell |
10,087
-9,487
| -48% | -$367K | ﹤0.01% | 2086 |
|
|
2021
Q3 | $1.06M | Buy |
+19,574
| New | +$1.06M | 0.01% | 1715 |
|
|
2021
Q1 | – | Sell |
-25,103
| Closed | -$440K | – | 2916 |
|
|
2020
Q4 | $440K | Buy |
+25,103
| New | +$440K | ﹤0.01% | 1818 |
|
|
2018
Q2 | – | Sell |
-1,783
| Closed | -$62K | – | 2790 |
|
|
2018
Q1 | $62K | Buy |
1,783
+787
| +79% | +$27.4K | ﹤0.01% | 2578 |
|
|
2017
Q4 | $42K | Sell |
996
-1,731
| -63% | -$73K | ﹤0.01% | 2479 |
|
|
2017
Q3 | $117K | Buy |
2,727
+916
| +51% | +$39.3K | ﹤0.01% | 2682 |
|
|
2017
Q2 | $67K | Buy |
1,811
+282
| +18% | +$10.4K | ﹤0.01% | 2593 |
|
|
2017
Q1 | $83K | Sell |
1,529
-2,884
| -65% | -$157K | ﹤0.01% | 2678 |
|
|
2016
Q4 | $234K | Buy |
+4,413
| New | +$234K | ﹤0.01% | 1976 |
|
|
2016
Q2 | – | Sell |
-2,194
| Closed | -$124K | – | 2178 |
|
|
2016
Q1 | $124K | Buy |
+2,194
| New | +$124K | ﹤0.01% | 2192 |
|
|
2015
Q4 | – | Sell |
-1,348
| Closed | -$213K | – | 2203 |
|
|
2015
Q3 | $213K | Sell |
1,348
-703
| -34% | -$111K | ﹤0.01% | 1422 |
|
|
2015
Q2 | $776K | Buy |
2,051
+874
| +74% | +$331K | 0.01% | 1062 |
|
|
2015
Q1 | $492K | Sell |
1,177
-250
| -18% | -$105K | ﹤0.01% | 1304 |
|
|
2014
Q4 | $391K | Buy |
+1,427
| New | +$391K | ﹤0.01% | 1638 |
|
|
2014
Q2 | – | Sell |
-1,929
| Closed | -$511K | – | 2109 |
|
|
2014
Q1 | $511K | Buy |
1,929
+1,492
| +341% | +$395K | ﹤0.01% | 1323 |
|
|
2013
Q4 | $159K | Sell |
437
-681
| -61% | -$248K | ﹤0.01% | 1893 |
|
|
2013
Q3 | $594K | Buy |
+1,118
| New | +$594K | ﹤0.01% | 1375 |
|